Do not ignore what HTFL is doing to this portfolio

Today's market and our positions

SPY dropped 1.2% today and closed near $762.49. That's not a panic number — but it's not nothing either. The tell was in the texture: soft all session, no real bounce attempt, no moment where buyers stepped in and said enough. That's the kind of tape that makes you watch your stops a little more closely. The good news is that most of what we're holding barely flinched. CRNX, which makes up 14 of our 23 open positions, was essentially unchanged across the board. TEAM and HURN kept doing their thing. HTFL kept doing its thing too, unfortunately. Through 75 days, the Relative Strength Engine is sitting at +3.5% alpha over SPY. Win rate shows 0/24 on closed trades — that number looks alarming until you remember we haven't closed anything yet, which makes it a placeholder, not a verdict.

What our open trades are doing

CRNX is the quiet engine running under this entire book. Fourteen entries spread across days 47 through 73, all sitting right at their entry prices, all accumulating alpha by doing one thing: not going down while SPY does. The longest position is on day 73. None of them are exciting. All of them are doing exactly what relative strength is supposed to do in a soft tape — hold the line. TEAM is doing the heavy lifting on P&L. The day-38 entry at $179.86 is now at $207.82, up 15.5%. Day 37 at $181.65 is up 14.4%. The day-16 entry at $186.31 is up 11.5%. Atlassian has been a clean hold — no drama, no scares, just a stock that keeps getting bought. HURN is quieter but every bit as solid: in at $158.90 on day 18, now sitting at $174.86, up 10% with +10.17% alpha. It tends to go overlooked because TEAM hogs the spotlight, but HURN is working. On the other side of the ledger: HTFL. Three positions, all negative. The day-17 entry at $50.49 is down 4.36%. Day-5 at $50.70 is down 4.75%. Day-4 at $50.35 is down 4.09%. The stock has moved against us consistently since entry and isn't showing any sign of turning. RNG is also in the red — day-9 down 3.1%, day-10 down 2.6%. Neither is at a stop level yet, but neither is a comfortable hold right now either.

Today's closed trades, post-mortem

No trades closed today. Nothing to post-mortem. The open book is the whole story right now — and tomorrow's scan will tell us whether that changes.

What could change by tomorrow's open

The sharpest risk heading into tomorrow is a SPY follow-through to the downside. A second consecutive down day with any acceleration would push RNG and HTFL closer to the point where a stop decision stops being hypothetical. CRNX has held up well, but 14 positions in the same name carries real concentration risk if biotech has a bad morning for any reason — an FDA calendar item, a peer's data read, anything that spooks the sector. TEAM and HURN have both built enough cushion that they'd need a meaningful reversal to start looking concerning. HTFL is the one worth watching most closely. Three entries, all negative, no sign of a turn. If tomorrow doesn't show something better, that conversation gets harder to defer.

What we're watching tomorrow

Tomorrow morning the engines run fresh scans. After a 1.2% down day on SPY, the tape usually resolves one of two ways — a flush that carves out a clean entry, or a snap-back that tests recent highs. The Relative Strength Engine tends to find better setups in both of those scenarios than it does in slow, directionless drift. The real question is whether today was the start of something or just a bad afternoon. We'll see what the scan says.